Further, vasculogenic mimicry, an insidious mechanism of de novo vasculogenesis by which cancer resists angiogenic arrest, was undermined by miR-101 mimics, which sabotaged TGF-β and SDF1 signaling in cancer-associated fibroblasts and impaired VE-cadherin expression [128]. The gene discussed is TGFB1; the disease is cancer.